In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
23 hours 42 min ago
1 week 5 days ago
2 weeks 1 day ago
2 weeks 3 days ago
6 weeks 6 days ago
7 weeks 6 days ago
8 weeks 10 hours ago
9 weeks 2 days ago
14 weeks 3 days ago
16 weeks 6 days ago